MedTrace Logo

MyIBD Care - Feasibility Study

NCT03958266 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-02-10

No results posted yet for this study

Summary

The aim of this study is appraise the safety and feasibility of utilising a novel mobile phone application and linked clinical platform to replace and enhance traditional outpatient appointments for patients with Inflammatory Bowel Diseases. The goal of this study is to demonstrate whether the platform can reduce the costs of managing patients on complex immunomodulators and biologic therapies whilst maintaining safety monitoring such as clinical patient reported outcome measures (PROMs), haematological and biochemical tests.

Conditions

  • Inflammatory Bowel Diseases

Interventions

DEVICE

MyIBD Care

Novel mobile phone application

Sponsors & Collaborators

  • King's College Hospital NHS Trust

    collaborator OTHER

  • Barts & The London NHS Trust

    lead OTHER

Principal Investigators

  • Bu Hayee, PhD, FRCP · King's College Hospital NHS Trust

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-31
Primary Completion
2020-09-30
Completion
2020-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03958266 on ClinicalTrials.gov